Cargando…

Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent

Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate (BZP) is a potential cardiovascular drug and exerts potent neuroprotective effect against transient and long-term ischemic stroke in rats. BZP could convert into 3-butyl-6-bromo-1(3H)-isobenzofuranone (Br-NBP) in vitro and in vivo. However, the pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xin, Li, Hong-Meng, Wei, Jing-Yao, Liu, Bing-Jie, Zhang, Yu-Hai, Wang, Gao-Ju, Chang, Jun-Biao, Qiao, Hai-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990024/ https://www.ncbi.nlm.nih.gov/pubmed/27588003 http://dx.doi.org/10.3389/fphar.2016.00255

Ejemplares similares

LC-MS/MS Analysis and Pharmacokinetics of Sodium (±)-5-Bromo-2-(α-hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-Ischemic Stroke Agent in Rats
por: Tian, Xin, et al.
Publicado: (2016)

Protective Effects of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate in a Rodent Model of Global Cerebral Ischemia
por: Gao, Yuan, et al.
Publicado: (2017)

Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy
por: Wang, Bo, et al.
Publicado: (2019)

Potassium 2-(1-hydroxypentyl)-benzoate improves depressive-like behaviors in rat model
por: Ma, Hao, et al.
Publicado: (2018)

Potassium 2-(1-hydroxypentyl)-benzoate attenuates neuronal apoptosis in neuron–astrocyte co-culture system through neurotrophy and neuroinflammation pathway
por: Liu, Dongmei, et al.
Publicado: (2017)

Potassium 2-(l-hydroxypentyl)-benzoate attenuates neuroinflammatory responses and upregulates heme oxygenase-1 in systemic lipopolysaccharide-induced inflammation in mice
por: Zhao, Chunyang, et al.
Publicado: (2017)

The attenuation effect of potassium 2‐(1‐hydroxypentyl)‐benzoate in a mouse model of diabetes‐associated cognitive decline: The protein expression in the brain
por: Yu, Wenwen, et al.
Publicado: (2022)

4-Bromophenyl benzoate
por: Gowda, B. Thimme, et al.
Publicado: (2008)

4-Methylphenyl 4-bromobenzoate
por: Moreno-Fuquen, Rodolfo, et al.
Publicado: (2011)

4-Nitrophenyl 4-bromobenzoate
por: Moreno-Fuquen, Rodolfo
Publicado: (2011)

Methyl 2-amino-5-bromobenzoate
por: Khan, Islam Ullah, et al.
Publicado: (2011)

Effects of bariatric surgery on drug pharmacokinetics—Preclinical studies
por: Mercado, Angela, et al.
Publicado: (2023)

2-(4-Bromophenyl)-2-oxoethyl 4-bromobenzoate
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
por: Liu, Yahong, et al.
Publicado: (2023)

Methyl 5-bromo-2-hydroxybenzoate
por: Mustafa, Ghulam, et al.
Publicado: (2012)

Methyl 4-bromo-3-hydroxybenzoate
por: Huang, Hua-Rong, et al.
Publicado: (2010)

3-(2-Bromoacetyl)phenyl benzoate
por: Ambekar, Sachin P, et al.
Publicado: (2013)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
por: Yang, Fen, et al.
Publicado: (2017)

Benzoate of Sodium in Uremia
Publicado: (1888)

Crystal structures of methyl 3,5-dibromo-4-cyanobenzoate and methyl 3,5-dibromo-4-isocyanobenzoate
por: Noland, Wayland E., et al.
Publicado: (2018)

eIF2α Kinases Regulate Development through the BzpR Transcription Factor in Dictyostelium discoideum
por: Singleton, Charles K., et al.
Publicado: (2012)

(±)-5-bromo-2-(5-fluoro-1-hydroxyamyl) Benzoate Protects Against Oxidative Stress Injury in PC12 Cells Exposed to H(2)O(2) Through Activation of Nrf2 Pathway
por: Qi, Saidan, et al.
Publicado: (2022)

2-Amino-5-bromopyridinium 3-aminobenzoate
por: Hemamalini, Madhukar, et al.
Publicado: (2010)

4-Formyl-2-nitrophenyl 4-bromobenzoate
por: Moreno-Fuquen, Rodolfo, et al.
Publicado: (2013)

Comparison of pharmacokinetics and safety between CE-fosphenytoin sodium, fosphenytoin sodium, and phenytoin sodium after intravenous and intramuscular administration in healthy volunteers
por: Li, Xiaojiao, et al.
Publicado: (2023)

Benzoate of Sodium in Throat Affections
Publicado: (1888)

2-Amino-5-bromopyridinium 2-hydroxybenzoate
por: Quah, Ching Kheng, et al.
Publicado: (2010)

2-Amino-5-bromopyridinium 2-carboxybenzoate
por: Quah, Ching Kheng, et al.
Publicado: (2010)

4-Bromo-2-(diethoxymethyl)phenyl benzoate
por: Sharmila, P., et al.
Publicado: (2013)

Methyl 2-bromo-3-(4-chlorobenzenesulfonamido)benzoate
por: Ghafoor, Ahmad Z., et al.
Publicado: (2013)

2,4,6-Trinitrophenyl 3-bromobenzoate
por: Moreno-Fuquen, Rodolfo, et al.
Publicado: (2014)

2,4,6-Trinitrophenyl 4-bromobenzoate
por: Moreno-Fuquen, Rodolfo
Publicado: (2013)

Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
por: Bao, Xiao-yi, et al.
Publicado: (2018)

Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs
por: Yuan, Yawen, et al.
Publicado: (2022)

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment
por: Wang, Amy Q., et al.
Publicado: (2022)

Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
por: Hong, Xiaodan, et al.
Publicado: (2022)

2-(4-Bromophenyl)-2-oxoethyl 4-chlorobenzoate
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

2-(4-Bromophenyl)-2-oxoethyl 4-methylbenzoate
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

2-(4-Bromophenyl)-2-oxoethyl 2-methylbenzoate
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

2-(4-Methylphenyl)-2-oxoethyl 3-bromobenzoate
por: Khan, Imtiaz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ljm0lds3ium3nn1qjgl2ov6qvh